Clover Health Investments (CLOV) Net Cash Flow (2020 - 2026)

Clover Health Investments has reported Net Cash Flow for 7 years, with the latest figure at $95.0 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 342.85% year-over-year to $95.0 million; the trailing twelve-month figure through Mar 2026 stood at $17.8 million (up 442.08% YoY), and the FY2025 full-year result was -$116.2 million, down 277.05% from the prior year.
• Net Cash Flow for Q1 2026 stood at $95.0 million, up from -$111.8 million in the prior quarter.
• The five-year high for Net Cash Flow was $119.5 million in Q2 2023, with the low at -$297.3 million in Q4 2022.
• Historically, Net Cash Flow has averaged -$10.6 million across 5 years, with a median of $24.2 million in 2024.
• Annual changes were most pronounced in 2022 — Net Cash Flow sank 404.32% — and 2023, when it surged 433.16%.
• Clover Health Investments' Net Cash Flow stood at -$297.3 million in 2022, then surged by 52.51% to -$141.2 million in 2023, then jumped by 67.56% to -$45.8 million in 2024, then sank by 143.96% to -$111.8 million in 2025, then surged by 184.98% to $95.0 million in 2026.
• The last three Net Cash Flow figures came in at $95.0 million (Q1 2026), -$111.8 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.